Avastin in combination with pemetrexed delivers promising outcomes
PointBreak: Avastin plus pemetrexed first line until PD
- In the ongoing PointBreak trial, patients are randomised to one of
- first-line Avastin 15mg/kg plus carboplatin/pemetrexed followed by Avastin plus pemetrexed until PD
- first-line Avastin, 15mg/kg every 3 weeks, plus carboplatin/paclitaxel followed by single-agent Avastin until PD.
- Primary endpoint
- Secondary endpoints
- ORR
- DCR
- PFS
- TTP
- safety
- QoL.
Next
Back